# Diclofenac Sodium Delayed Release (Diclofenac Sodium) by Preferred Pharmaceuticals Inc.: new human prescription drug listing

**Launch Signal Score:** 65/100

| Field | Value |
|---|---|
| Product | Diclofenac Sodium Delayed Release |
| Generic name | Diclofenac Sodium |
| NDC | 68788-4194 |
| Labeler | Preferred Pharmaceuticals Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Approval pathway | ANDA |
| Application number | ANDA075185 |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Active ingredients | DICLOFENAC SODIUM 75 mg/1 |
| Marketing start | 2026-09-24 |
| Package configurations | 5 |

## Why this score
- Prescription or biologic product.
- New generic entry: wholesalers and GPOs re-bid contracts.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=68788-4194). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.